Australia is on track to eliminate cervical cancer as a public health issue in two decades, says a new study.
The disease, which affected 930 Australian women in 2018, would become a “rare cancer” in Australia by 2022, as by them it is predicted to affect less than six per 100,000 people.
Australia was one of the first countries in the world to introduce a Human Papilloma Virus (HPV) vaccination scheme for girls, in 2007. It already had a national screening programme running since 1991.
As per the new model, published by Cancer Council New South Wales (NSW), a charity, in The Lancet Public Health Journal, cancer will affect just four in 100,000 women by 2035. Currently, the ratio is about seven per 100,000 – half the global average.
HPV is fourth-most frequent cancer in women and the sexually transmitted infection has a high mortality rate globally.